DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/7wv7zz/future_horizons) has announced the addition of the "Future Horizons in the Global CMV Diagnostic Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country" report to their offering.
The report presents a detailed analysis of the Cytomegalovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the CMV definition, epidemiology and etiology are reviewed.
The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
- Blood Banks
- Physician Offices
- Public Health Labs
For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of CMV tests.
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 231 pages and 15 tables
Key Topics Covered:
I. Introduction
II. CMV Worldwide Market and Technology Overview
III. France: Market Size, Growth and Major Suppliers' Sales and Market Shares
IV. Germany: Market Size, Growth and Major Suppliers' Sales and Market Shares
V. Italy: Market Size, Growth and Major Suppliers' Sales and Market Shares
VI. Japan: Market Size, Growth and Major Suppliers' Sales and Market Shares
VII. Spain: Market Size, Growth and Major Suppliers' Sales and Market Shares
VIII. UK: Market Size, Growth and Major Suppliers' Sales and Market Shares
IX. USA: Market Size, Growth and Major Suppliers' Sales and Market Shares
X. Alternative Market Penetration Strategies
XI. Potential Market Entry Barriers and Risks
XII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Enzo Biochem
- Fujirebio
- Gen-Probe
- Hologic
- ID Biomedical
- Innogenetics/Solvay
- Kreatech
- Life Technology
- Lonza
- Nanogen/Elitech
- Novartis Diagnostics
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
For more information visit http://www.researchandmarkets.com/research/7wv7zz/future_horizons